• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.

作者信息

Anderson J R, Cain K C, Gelber R D, Gelman R S

出版信息

Cancer Treat Rep. 1985 Oct;69(10):1139-46.

PMID:3899355
Abstract
摘要

相似文献

1
Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials.
Cancer Treat Rep. 1985 Oct;69(10):1139-46.
2
[Progress in breast cancer chemo-endocrine therapy from the survival standpoint].
Gan To Kagaku Ryoho. 1995 May;22(6):726-31.
3
A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations.环磷酰胺-米托蒽醌-5-氟尿嘧啶与环磷酰胺-阿霉素-5-氟尿嘧啶治疗晚期乳腺癌的随机对照比较：初步观察
Semin Oncol. 1984 Sep;11(3 Suppl 1):23-7.
4
[Adriamycin--breast cancer].[阿霉素——乳腺癌]
Gan To Kagaku Ryoho. 1996 Dec;23(14):1911-5.
5
Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.接受大剂量化疗及自体血干细胞支持的转移性乳腺癌患者中C-erbB-2/HER-2的表达
Bone Marrow Transplant. 1999 Aug;24(4):377-84. doi: 10.1038/sj.bmt.1701907.
6
Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.环磷酰胺、阿霉素和氟尿嘧啶（CAF）联合亚叶酸钙与CAF治疗转移性乳腺癌的III期研究：癌症与白血病B组9140研究
J Clin Oncol. 2003 May 1;21(9):1819-24. doi: 10.1200/JCO.2003.05.119.
7
[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].[化疗中剂量强度的重要性——早期乳腺癌辅助化疗的经验教训]
Rinsho Ketsueki. 2009 Apr;50(4):276-81.
8
[Inflammatory carcinoma of the breast. Experience of 43 cases at the Instituto do Câncer Arnaldo Vieira de Carvalho].[乳房炎性癌。阿尔纳尔多·维埃拉·德·卡瓦略癌症研究所43例病例的经验]
Rev Paul Med. 1988 Jan-Feb;106(1):14-20.
9
Randomized, comparative study of high-dose (with autologous bone marrow support) versus low-dose cyclophosphamide, cisplatin, and carmustine as consolidation to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for patients with operable stage II or III breast cancer involving 10 or more axillary lymph nodes (CALGB Protocol 9082). Cancer and Leukemia Group B.随机对照研究：高剂量（联合自体骨髓支持）与低剂量环磷酰胺、顺铂和卡莫司汀作为可手术的Ⅱ期或Ⅲ期乳腺癌且腋窝淋巴结转移≥10枚患者辅助化疗中环磷酰胺、多柔比星和氟尿嘧啶巩固治疗的比较（癌症与白血病B组9082方案）。癌症与白血病B组
J Natl Cancer Inst Monogr. 1995(19):41-4.
10
Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.淋巴结阴性、雌激素受体阴性乳腺癌的辅助化疗：三项试验的故事
J Natl Cancer Inst. 2004 Dec 15;96(24):1801-4. doi: 10.1093/jnci/djh347.

引用本文的文献

1
Suggestions on Using Machine Learning Models and Cautions for Analyzing Censored Time-To-Event Outcomes.关于使用机器学习模型的建议以及分析删失的事件发生时间结局时的注意事项。
JCO Precis Oncol. 2024 May;8:e2400220. doi: 10.1200/PO.24.00220.
2
Reporting and methodological quality of survival analysis in articles published in Chinese oncology journals.中国肿瘤学期刊发表文章中生存分析的报告与方法学质量
Medicine (Baltimore). 2017 Dec;96(50):e9204. doi: 10.1097/MD.0000000000009204.
3
Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial.
选择性内照射治疗单次给药与索拉非尼持续治疗用于局部晚期肝细胞癌的对比研究（SIRveNIB）：一项III期随机对照试验的研究方案
BMC Cancer. 2016 Nov 7;16(1):856. doi: 10.1186/s12885-016-2868-y.
4
Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?舒尼替尼治疗的肾细胞癌患者发生骨转移是否会影响总生存期？
World J Urol. 2016 Jul;34(7):909-15. doi: 10.1007/s00345-015-1707-0. Epub 2015 Nov 19.
5
Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303).诱导使用西妥昔单抗、紫杉醇和卡铂，随后对 III/IV 期头颈部鳞状癌进行西妥昔单抗、紫杉醇和卡铂同步放化疗：一项 II 期 ECOG-ACRIN 试验（E2303）。
Ann Oncol. 2014 Oct;25(10):2036-2041. doi: 10.1093/annonc/mdu248. Epub 2014 Jul 9.
6
Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93.SERM 依从性对治疗效果的影响：国际乳腺癌研究组试验 13-93 和 14-93。
Breast Cancer Res Treat. 2013 Nov;142(2):455-9. doi: 10.1007/s10549-013-2757-x. Epub 2013 Nov 7.
7
Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.ECOG 4599 研究中卡铂和紫杉醇联合贝伐珠单抗治疗的晚期非小细胞肺癌患者发生高血压的临床过程。
J Clin Oncol. 2010 Feb 20;28(6):949-54. doi: 10.1200/JCO.2009.25.4482. Epub 2010 Jan 19.
8
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.非霍奇金淋巴瘤患者接受减低强度异基因造血干细胞移植后，移植前和早期移植后反应评估与结局的相关性。
Cancer. 2010 Feb 15;116(4):852-62. doi: 10.1002/cncr.24845.
9
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.内分泌反应性对接受剂量密集化疗的高危乳腺癌的影响：国际乳腺癌研究组15-95试验延长随访后的结果
Ann Oncol. 2009 Aug;20(8):1344-51. doi: 10.1093/annonc/mdp024. Epub 2009 May 25.
10
Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery.癌症手术中生存机会的Kaplan-Meier计算法的益处与局限性
Langenbecks Arch Surg. 2003 Sep;388(4):239-44. doi: 10.1007/s00423-003-0410-6. Epub 2003 Aug 14.